Objective: Skeletal muscle AMP-activated protein kinase (AMPK)a2 activity is impaired in obese, insulin-resistant individuals during exercise. We determined whether this defect contributes to the metabolic dysregulation and reduced exercise capacity observed in the obese state. Design: C57BL/6J wild-type (WT) mice and/or mice expressing a kinase dead AMPKa2 subunit in skeletal muscle (a2-KD) were fed chow or high-fat (HF) diets from 3 to 16 weeks of age. At 15 weeks, mice performed an exercise stress test to determine exercise capacity. In WT mice, muscle glucose uptake and skeletal muscle AMPKa2 activity was assessed in chronically catheterized mice (carotid artery/jugular vein) at 16 weeks. In a separate study, HF-fed WT and a2-KD mice performed 5 weeks of exercise training (from 15 to 20 weeks of age) to test whether AMPKa2 is necessary to restore work tolerance. Results: HF-fed WT mice had reduced exercise tolerance during an exercise stress test, and an attenuation in muscle glucose uptake and AMPKa2 activity during a single bout of exercise (Po0.05 versus chow). In chow-fed a2-KD mice, running speed and time were impaired B45 and B55%, respectively (Po0.05 versus WT chow); HF feeding further reduced running time B25% (Po0.05 versus a2-KD chow). In response to 5 weeks of exercise training, HF-fed WT and a2-KD mice increased maximum running speed B35% (Po0.05 versus pre-training) and maintained body weight at pre-training levels, whereas body weight increased in untrained HF WT and a2-KD mice. Exercise training restored running speed to levels seen in healthy, chow-fed mice. Conclusion: HF feeding impairs AMPKa2 activity in skeletal muscle during exercise in vivo. Although this defect directly contributes to reduced exercise capacity, findings in HF-fed a2-KD mice show that AMPKa2-independent mechanisms are also involved. Importantly, a2-KD mice on a HF-fed diet adapt to regular exercise by increasing exercise tolerance, demonstrating that this adaptation is independent of skeletal muscle AMPKa2 activity.
Introduction
Obesity is a primary risk factor for disease states associated with the metabolic syndrome (that is, Type 2 diabetes and cardiovascular disease), and regular physical exercise has long been recognized as an essential component in the treatment of obesity. 1 A limiting factor for exercise as a therapeutic option is that obesity is characterized by impaired exercise tolerance, yet the limiting factor(s) responsible for this phenomenon is unclear. An enzyme that appears to have a significant role in the promotion of exercise tolerance is the serine-threonine AMP-activated protein kinase (AMPK), whose activation is increased in response to elevations in metabolic cellular stress. 2 In lean otherwise healthy mice expressing a kinase-dead form of the catalytic AMPKa2 subunit in skeletal muscle (a2-KD), exercise tolerance is markedly impaired. 3, 4 AMPKa2 activity is also impaired in skeletal muscle of obese individuals during moderate intensity exercise; 5 however, whether this defect directly contributes to the reduced exercise capacity observed under obese conditions is unknown.
Here we utilized wild-type (WT) and a2-KD mice to elucidate the role of AMPKa2 in the regulation of exercise tolerance under high-fat (HF) fed, obese conditions. We hypothesized that (1) diet-induced obesity would significantly impair skeletal muscle AMPKa2 activity during exercise in vivo and (2) that this impairment in skeletal muscle AMPKa2 activity significantly contributes to exercise intolerance. Regular physical activity is a common therapeutic recommendation for obese individuals. 6 Thus, we also tested whether a 5 week exercise training regimen would be effective in increasing exercise tolerance in HF-fed WT and a2-KD mice.
Materials and methods

Animal maintenance
All procedures were approved by the Vanderbilt University Animal Care and Use Committee. Male and female C57BL/6J a2-KD mice 7 and WT littermate mice were studied. At 21 days after birth, littermates were separated by gender and maintained in microisolator cages. Following separation, mice were fed a standard chow (5.5% fat by weight; 5001 Laboratory Rodent Diet, Purina, Richmond, IN, USA) or HF diet (35.5% fat by weight; diet F3282, Bio-Serv Inc., Frenchtown, NJ, USA) and had access to water ad libitum until they were 16-20 weeks of age.
Exercise stress test
In chow-and HF-fed WT and a2-KD mice, peak oxygen consumption ( . VO 2peak ) was assessed at 15 weeks of age using an exercise stress test protocol as previously described 3 . Briefly, following a 10-min-acclimation period 2 days before the stress test, mice were placed in an enclosed single lane treadmill connected to Oxymax oxygen and carbon dioxide sensors (Columbus Instruments, Columbus, OH, USA). Following a 30-min-basal period, mice commenced running at 10 m min À1 on a 0% incline. Running speed was increased by 4 m min À1 every 3 min until mice reached exhaustion, defined as the point whereby mice remained at the back of the treadmill on an electric shock pad for 5 s. Body weight was measured before the . VO 2peak test and body composition was assessed using an mq10 NMR analyzer (Bruker Optics, The Woodlands, TX, USA). All oxygen consumption measurements were expressed per kilogram of lean body mass (kg LBM ).
Acute exercise
To examine whether a HF diet impaired skeletal muscle glucose uptake and AMPKa2 activation during acute exercise in WT mice, 5-h fasted 16-week-old chow-and HF-fed WT mice either remained sedentary on a treadmill, or performed a single bout of treadmill exercise for 30 min at 16 ]deoxyglucose in the gastrocnemius was determined as previously described. 3 Indices for glucose metabolism (R g ) and clearance (K g ) were determined in chow-and HF-fed WT mice as previously described. Whole-cell lysates were prepared as previously described 3 using a lysis buffer containing 50 mM Tris-HCl (pH 7.5), 1 mM EDTA, 1 mM ethylene glycol tetraacetic acid, 10% glycerol, 1% Triton X-100, 1 mM dithiothreitol, 1 Â HALT protease and phosphatase inhibitor cocktail (Thermo Scientific, Rockford, IL, USA). Nuclear and cytosolic fractions were prepared using the methods of McGee et al. 9 Gastrocnemius samples were homogenized in buffer A (250 mM sucrose, 10 mM NaCl, 3 mM MgCl, 1 mM dithiothreitol, 1 Â HALT protease and phosphatase inhibitor cocktail) using a handheld pellet pestle and centrifuged at 500 g. The supernatant (cytosolic fraction) was snap frozen in liquid nitrogen and stored at À80 1C. The pellet was re-suspended in buffer B (50 mM Tris-HCl (pH 7.5), 1 mM EDTA (pH 8.0), 1 mM ethylene glycol tetraacetic acid, 10% glycerol, 1% Triton X-100, 50 mM MgCl, 1 mM dithiothreitol, 1 Â HALT protease and phosphatase inhibitor cocktail), kept on ice for 10 min and centrifuged at 3000 g. The resulting supernatant (nuclear fraction) was snap frozen and stored at À80 1C. Immunoblotting AMPKa2 protein expression was determined from immunoprecipitated samples from whole-cell lysates, or from 20 mg of nuclear and 40 mg of cytosolic fractions. Acetyl-CoA carboxylase (ACC)b expression and phosphorylation were assessed from 200 mg of whole-cell lysate that had been affinity purified overnight at 4 1C using streptavidin agarose beads (Invitrogen, Carlsbad, CA, USA). Proteins were separated using NuPAGE 4-12% Bis-Tris Gels (Invitrogen) and transferred to polyvinylidene fluoride membranes. Blots were probed with an anti-AMPKa2 goat polyclonal antibody (1:100; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-AMPKa Thr 172 rabbit polyclonal antibody (1:100; Cell Signaling, Danvers, MA, USA), or an anti-ACCb Ser 221 rabbit polyclonal antibody (1:100; Cell Signaling). Antibody binding was detected with an IRDye 800-conjugated anti-goat and anti-rabbit IgG secondary antibody (Rockland, USA). ACCb protein expression was detected using IRDye 800-labeled streptavidin (Rockland Immunochemicals Inc., Gilbertsville, PA, USA).
Statistical analyses
Data are mean±s.e.m.. Statistical analysis was performed using a Student's t-test, one-way analysis of variance (ANOVA), or two-way repeated measures ANOVA were appropriate with the statistical software package SigmaStat (SPSS Inc., Somers, NY, USA). If the ANOVA was significant (Po0.05), specific differences were located using Fisher's least significant difference test.
Results
Obesity impairs exercise capacity At 16 weeks of age, HF-fed WT mice weighed more than chow-fed WT mice (37±2 versus 24±2 g, Po0.001) owing to greater fat mass (33 ± 2 versus 9 ± 2% body weight, Po0.001).
In response to an exercise stress test, HF-fed WT mice were exercise intolerant as evidenced by impairments in running speed (30 ± 1 versus 38 ± 1 m min À1 for HF and chow, respectively; Po0.001), running time (17 ± 1 versus 23±1 min; Po0.001) and a B40% impairment in . VO 2peak (77 ± 6 versus 127 ± 5 ml kg LBM À1 min
À1
; Po0.05).
Obesity impairs the exercise-induced increase in skeletal muscle glucose uptake and AMPKa2 activity in vivo In the sedentary state, blood glucose was higher in HF-fed mice compared with chow-fed controls (10.7±0.5 versus 9.1 ± 0.9 mM during the 30 min sedentary period; Po0.05).
In response to 30 min of treadmill exercise, blood glucose significantly increased over time in chow-and HF-fed mice, although blood glucose was consistently elevated in HF-fed mice ( Figure 1a) . The gastrocnemius muscle glucose metabolic index (R g ; Figure 1b ) and gastrocnemius glucose clearance (K g ; Figure 1c ) increased Bsixfold and Bfourfold, respectively, during exercise in chow-fed mice. Increases with exercise were significantly attenuated in HF-fed mice. Under basal conditions, no differences were observed for whole-cell AMPKa2 activity or AMPKa2 Thr Figure 1f ). In contrast, these exercise-induced increases were all ablated in HF-fed WT mice. We next assessed whether the impairment in whole-cell AMPKa2 activity was localized to specific subcellular compartments. Nuclear AMPKa2 activity in response to exercise tended to increase in chow-fed mice (P ¼ 0.09 versus sedentary); nuclear AMPKa2 activity in response to exercise was significantly reduced in HF-fed mice compared with chow-fed mice (Figure 2a) . Likewise, cytosolic AMPKa2 activity increased during exercise in chow-fed mice, whereas no increase was seen in HF-fed mice (Figure 2b ). The suppressed nuclear and cytosolic AMPKa2 activity in HFfed mice was not owing to reduced AMPKa2 protein expression (Figures 2c and d) . Indeed, the exercise-induced increase in nuclear AMPKa2 activity of chow-fed WT mice occurred despite lower protein levels of AMPKa2.
AMPK-dependent and AMPK-independent factors regulate exercise capacity in obese states Our findings above demonstrate that a HF diet impairs exercise capacity during an exercise stress test. To determine the degree to which the impaired exercise capacity in HF-fed mice was directly dependent upon impaired activation of AMPKa2, chow-and HF-fed a2-KD mice were subjected to an exercise stress test. a2-KD mice were utilized as AMPKa2 activity is essentially abolished in skeletal muscle of these Obesity, AMP-activated protein kinase and exercise RS Lee-Young et al mice both at rest and in response to moderate intensity exercise in vivo. 3 In a2-KD mice, HF-feeding resulted in similar changes in body composition to that of HF-fed WT mice (data not shown). As expected, 3 chow-fed a2-KD mice had impairments in running speed and running time compared with chow-fed WT mice (B45 and B55% reduction, respectively; Po0.001). . VO 2peak during the exercise stress test was also reduced in chow-fed a2-KD versus WT mice ( Figure 3) ; however, . VO 2peak for chow-fed a2-KD mice was higher than that observed in HF-fed WT mice. HF feeding further reduced . VO 2peak in a2-KD mice; in fact, no significant increase in . VO 2 was observed during the exercise stress test (Figure 3 ). HF feeding also reduced running time in a2-KD mice (7.6 ± 0.9 versus 10.0 ± 0.9 min for HF-fed and chow a2-KD mice, respectively; Po0.05), although there was a tendency for reduced maximum running speed (18 ± 1 versus 21 ± 1 m min
; P ¼ 0.06).
In chow-and HF-fed a2-KD mice the increase in . VO 2 (D . VO 2 ) during the exercise stress test was 22 ± 4 and 5 ± 2 ml kg LBM À1 min
, respectively. As AMPKa2 is not activated in these mice, the difference between these variables Obesity, AMP-activated protein kinase and exercise RS Lee-Young et al (17 ± 2 ml kg LBM À1 min
) represents an AMPKa2-independent component with regard to D . VO 2 during an exercise stress test. In WT mice, D . VO 2 was impaired by 40 ± 2 ml kg LBM À1 min À1 in response to HF feeding. Therefore, B45% of this impairment (that is, B17 ml kg LBM À1 min
) in HF-fed WT mice is due to AMPKa2-independent mechanisms (that is, the remaining B55% of the impaired D . VO 2 in HF-fed WT mice is AMPKa2-dependent). The contributions of AMPKa2-dependent and independent components are shown in Figure 4 .
Exercise training improves exercise capacity of HF-fed mice independently of AMPKa2 in skeletal muscle
To determine whether normal AMPKa2 activity is necessary for a training-induced increase in exercise capacity, HF-fed WT and a2-KD mice performed 5 weeks of exercise training or remained sedentary beginning at 15 weeks of age. Sedentary WT and a2-KD mice significantly increased body weight over the 5-week period (Table 1) , and had no improvement in maximum running speed ( Figure 5) . In contrast at 20 weeks, trained HF-fed WT mice maintained body weight at pre-training levels (Table 1) , and increased maximum running speed by 34 ± 6% ( Figure 5 ). Indeed, maximum running speed returned to levels observed in lean, healthy untrained WT mice. Although in absolute terms running speed remained impaired in HF-fed a2-KD mice after training, trained a2-KD mice had a similar relative increase in maximum running speed (35±6% versus week 15) when compared with trained WT mice. As with HF-fed WT mice, trained HF-fed a2-KD mice were able to maintain body weight at pre-training levels (Table 1) . Thus, mice expressing a catalytically inactive AMPKa2 subunit in skeletal muscle respond normally to exercise training. The fact that a2-KD mice elicited a similar relative increase in exercise capacity after training, and were also able to maintain body weight, shows that these adaptations to training occur independently of skeletal muscle AMPKa2.
Discussion
Regular physical exercise has long been recognized as an essential component in the treatment of obesity, owing to the beneficial effects on weight maintenance/reduction and lowering the risk of developing Type 2 diabetes and cardiovascular disease. 1, 6 Here, we show that skeletal muscle AMPKa2 has a significant role in one's ability to Figure 4 Oxidative capacity during exercise is regulated via AMPKa2-dependent and -independent components. D . VO 2 , change in oxygen consumption; WT, wild-type; a2-KD, AMPKa2 kinase-dead; HF, high fat. kg LBM , kilograms of lean body mass. Obesity, AMP-activated protein kinase and exercise RS Lee-Young et al fully utilize exercise as a preventative or interventional treatment option. Indeed, we show that the suppression in AMPKa2 activation observed during acute exercise under obese, insulin-resistant conditions has a significant role in the impaired exercise capacity also observed under these conditions. However, the physiological adaptation to exercise training occurs regardless of whether AMPKa2 is activated, as a catalytically inactive AMPKa2 subunit does not attenuate the relative increase in exercise capacity seen following 5 weeks of exercise training. Thus, although AMPKa2 has a key role in the regulation of exercise capacity, factors independent of AMPKa2 are also involved.
In the present study we utilized an exercise stress test, a non-invasive tool that has long been used to diagnose certain disease states in humans, 10, 11 to identify AMPKa2-dependent and AMPKa2-independent components involved in the regulation of exercise capacity. Both diet-and genotypespecific effects were observed in the present study. Taken together with previous observations in lean, healthy mice expressing a catalytically inactive AMPKa2 subunit, 3, 7, 12 as well as other genetically modified mice with impaired AMPKa2 activation 13, 14 it can be seen that skeletal muscle AMPKa2 clearly has a role in the regulation of exercise capacity in vivo. Likewise, impaired AMPKa2 activity in obese WT mice was also associated with a reduction in exercise capacity; however, our finding that HF feeding further reduced exercise capacity in a2-KD mice shows that AMPKa2-independent mechanisms also regulate exercise capacity. The relative contributions of AMPK-dependent and AMPK-independent components are shown in Figure 4 . Our data clearly show that the dysregulation of AMPKa2 in skeletal muscle, whether in lean or obese states, significantly reduces exercise tolerance in vivo. This highlights the significant role of AMPKa2 in the physiological response to exercise. The finding that the increase in . VO 2 was fully suppressed during the exercise stress test in HF-fed a2-KD mice is remarkable. It is unlikely that this phenomenon is owing to cardiac dysfunction arising from expression of the a2-KD transgene in cardiac muscle, as glucose uptake, heart rate and cardiac output are normal during exercise in chow-fed a2-KD mice. 3 We have shown that chow-fed a2-KD mice exhibit vascular dysfunction, as evidenced by the inability to increase fractional cardiac output (assessed via microsphere deposition) in skeletal muscle during exercise. 3 It is possible that HF feeding per se exacerbated this impairment in vascular dysfunction in a2-KD mice. Regardless, it is clear that these mice are heavily reliant on anaerobic sources in order to perform exercise; however, the factor(s) responsible for this phenomenon is unclear. Although chow-fed a2-KD mice also have a greater reliance on anaerobic sources during exerciseFdue to impairments in complex I and IV activities of the electron transport chain (ETC) 3 Fit has recently been shown that some of these differences are not apparent in HF-fed a2-KD and WT mice. 15 Indeed, expression of different ETC complexes is actually increased in WT and a2-KD mice following HF feeding. 15 Nevertheless, diet-induced obesity is characterized by enhanced release of reactive oxidative species and impaired mitochondrial function; 16 however, it is unclear whether AMPKa2 has a role in this process.
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Thus, although the exact mechanism(s) accounting for the suppression of . VO 2 during the exercise stress test in HF-fed a2-KD mice is unclear, it is highly likely that there is an element of vascular dysfunction.
An important finding from the present study was that AMPKa2 activity was impaired in different subcellular compartments (that is, nuclear and cytosolic) of HF-fed WT mice during exercise. These differences were not due to reduced AMPKa2 expression within these compartments. Indeed, nuclear AMPKa2 expression was reduced in chowfed WT mice during exercise when compared with HF-fed WT mice, yet nuclear AMPKa2 activity tended to be higher in chow-fed WT mice under these conditions. The functional result of impaired AMPKa2 activity in these different compartments has important implications. Cell culture studies have shown that AMPK is at least partially required for GLUT-4 transcription. 18 Likewise, the exercise-induced increase in PGC-1a mediated nuclear-encoded mitochondrial genes is impaired in obese versus lean individuals, a phenomenon associated with impaired AMPK activation during exercise in obese individuals. 19 In contrast, evidence from global AMPKa2 knockout mice suggests that AMPKa2 is not required for certain metabolic adaptations to exercise training. Indeed, in ampka2 À/À mice, key enzymes involved in glucose metabolism (that is, GLUT4 and hexokinase II) increase in a similar manner to WT mice following 28 days of wheel running. 20 Consistent with these findings, we show that the capacity to improve exercise performance is retained following exercise training in HF-fed mice with impaired AMPKa2 activity. As mentioned above, both HF-fed WT and a2-KD mice are able to increase exercise capacity in response to exercise training. Given that AMPKa2 activity is essentially abolished in a2-KD mice, 3 this training-induced increase in exercise capacity clearly occurs via AMPKa2-independent mechanisms. This is evidenced by the almost identical relative increase in maximum running speed between genotypes (B35%) when compared with respective pre-training levels. This is the first study to show that obese mice lacking a catalytically active AMPKa2 subunit can increase exercise capacity in response to exercise training. In the present study, the training protocol employed involved mice exercising for the same amount of time at the same relative intensity. This meant that WT mice were constantly exercising at a greater absolute running speed than a2-KD mice. We chose to exercise a2-KD mice at the same relative work intensity as WT mice, as exercising at the same relative intensity elicits similar increases in muscle cellular stress between the two genotypes, whereas at the same absolute running speed cellular stress is lower in WT mice. 3 It should be noted that in the present study we assessed the extreme condition of HF-fed mice with and without a mutated AMPKa2 subunit. It is reasonable to assume that under the Obesity, AMP-activated protein kinase and exercise RS Lee-Young et al less extreme condition of chow feeding, lean mice would adapt to regular exercise as well. Importantly, we show that HF-fed obese mice were able to obtain a normal capacity to perform physical exercise after 5 weeks of training, despite reduced and even absent AMPK activity. This phenomenon is likely to be at least partially owing to increases in mitochondrial markers, GLUT-4, and hexokinase II, all of which increase in an AMPKa2-independent manner following exercise training. 20 In skeletal muscle, AMPKa2 has been hypothesized as a key regulator of muscle glucose uptake. Here, we demonstrate that in HF-fed WT mice, a partial impairment in the exercise-induced increase in R g occurred concomitantly with impaired activation of AMPKa2. It is notable that the impaired AMPKa2 activity in HF-fed WT mice occurred even though these mice exercised at a higher percentage of maximum running speed. HF-fed WT mice were exercising at B50% of maximum running speed whereas chow-fed WT mice were exercising at B40% of maximum running speed, further highlighting the inhibitory effect of HF feeding on skeletal muscle AMPKa2 activation during exercise in vivo. Despite the impairment in AMPKa2 activity in HF-fed mice during exercise, it is unlikely that this phenomenon directly accounted for the reduction in the exercise-induced increase in R g . Previous studies from our laboratory 3 and others 21 have demonstrated that the tissue extraction of glucose and GLUT-4 translocation during exercise in healthy a2-KD mice occur at levels similar to that of WT mice. Rather, the attenuation of muscle glucose uptake during exercise in a2-KD mice is due to an impaired fraction of cardiac output to skeletal muscle and thus, reduced glucose delivery to skeletal muscle. It is notable that HF-fed WT mice, that have impaired AMPKa2 activation during exercise, are also characterized by vascular dysfunction. 22 In conclusion, principles of exercise testing were uniquely applied to mice expressing a kinase-dead AMPKa2 protein in skeletal muscle to determine the mechanisms of exercise intolerance in response to HF feeding. The exercise intolerance arising from HF feeding was due to AMPKa2-dependent and AMPKa2-independent dysfunction. The AMPKa2-dependent exercise-intolerance in HF-fed mice was owing to diminished AMPKa2 activity in both nuclear and cytosolic fractions of skeletal muscle during exercise. Nevertheless, ablation of AMPKa2 activity in skeletal muscle did not prevent the restoration of normal work tolerance in HF-fed mice in response to exercise training. This emphasizes the value of regular physical activity even in subjects in whom muscle AMPKa2 activity is reduced, such as in obesity.
